Twitter | Search | |
Aju Mathew
Cancer doc, public health and global oncology researcher. via Trivandrum, Stockholm, Cambridge and Pittsburgh.
2,670
Tweets
243
Following
492
Followers
Tweets
Aju Mathew retweeted
John 6h
Replying to @ajumathew_
I think science and journalism face very similar crises today. The Many who lack the time and/or expertise to independently evaluate the facts/data have lost faith in the objectivity of those they formerly relied upon to do this on their behalf. /1
Reply Retweet Like
Aju Mathew 6h
Replying to @dan_smithey
That’s right.
Reply Retweet Like
Aju Mathew 7h
Replying to @ajumathew_
Reply Retweet Like
Aju Mathew 7h
The problem with science is that we tend to hype our research results and successes. I’m guilty of the same too. The only paper I’ve seen which has underplayed the significance of findings was the DNA paper in Nature from Watson and Crick.
Reply Retweet Like
Aju Mathew retweeted
Alok Khorana 8h
Absolutely, as reflected by increase in 90d mortality as interval increases
Reply Retweet Like
Aju Mathew 8h
Adjunctive steroids for pts in ICU with septic shock. Prim endpt no difference. But some clinically meaningful benefits. No big harms. Continue the practice?
Reply Retweet Like
Aju Mathew 8h
Isn't the study findings impacted by potential bias? Those who are sicker may be operated much later than those who are healthier? Any RCT that can help guide appr time for surgery post-CRT for stage III esoph ca?
Reply Retweet Like
Aju Mathew 10h
You are so calm and composed. 😀
Reply Retweet Like
Aju Mathew retweeted
FabriceAndreMD 13h
Pioneer paper on ESR1 fusions and resistance to endocrine therapy. next Q: incidence ? co-existence with esr1 mutations ? sensisity to SERD ?
Reply Retweet Like
Aju Mathew Jan 18
Replying to @bentosnbuttons
You are my first friend from the small state. 😀
Reply Retweet Like
Aju Mathew Jan 18
Replying to @bentosnbuttons
That’s wonderful. Great to know your story. If you visit Kerala with family, let me know. Would love to host you.
Reply Retweet Like
Aju Mathew retweeted
Richard Dunne Jan 18
Important distinction from where treatment failure rates are much lower in those with CR who are on observation
Reply Retweet Like
Aju Mathew Jan 18
Replying to @bentosnbuttons
Absolutely. By the way, how are you connected to Kerala?
Reply Retweet Like
Aju Mathew Jan 18
Real success in Medicine is when you make yourself irrelevant. Like this doctor who runs India’s only polio ward.
Reply Retweet Like
Aju Mathew Jan 17
Oh - only you can tweet/write/think like you do. Hilarious take-down of the parachute analogy vs RCT's.
Reply Retweet Like
Aju Mathew Jan 17
We had a great case-based discussion on myeloid sarcoma in fellow conference . It ceases to amaze me how little we know of how to appropriately treat various cancers despite tremendous technological advancements. Such a complex disease.
Reply Retweet Like
Aju Mathew Jan 17
Here’s one reason why MDR TB exists.
Reply Retweet Like
Aju Mathew Jan 17
That’s commendable visionary leadership
Reply Retweet Like
Aju Mathew retweeted
Binaytara Foundation Jan 16
Announcement: Abstract Deadline Extended!
Reply Retweet Like
Aju Mathew retweeted
Binaytara Foundation Jan 16
What do you want answered during this debate? Retweet a question and we might pose is to one of our panelists at April 28-29 in Seattle.
Reply Retweet Like